Recro Pharma of Malvern was one of several companies from the region who were showcased at BioTech 2011 last week at the Pennsylvania Convention Center, and MedCity News has a write-up and video on its new drug that targets postoperative and diabetes pain.
This year’s innovation corridor included about 24 scientists and early stage startups from universities and incubators who exhibited posters that highlighted their work and demonstrated the commercial applications, something that regional associations are trying to do more. Now in its sixth year, a decision was made to put the younger scientists alongside the more mature startups so potential investors could see them at the same time and encourage mentoring and partnership opportunities.
Recro Pharma, a Malvern, Pennsylvania-based company, is seeking $20 million for a new drug application for a drug that targets postoperative and diabetes pain relief.
Original source: MedCity News
Read the full story
here.